About Beacon Clinical Registry
We exist for the innovative clinician whose work deserves to be in the literature — and for the patient whose experience deserves to be in the evidence base.
A service of Beacon Life Sciences LLC, a Wyoming limited liability company.
Our mission
Most of the innovative therapies that will define the next decade of medicine are already in practice — somewhere. Regenerative therapies. Peptides. Gene therapies. Neurorehabilitation protocols. Functional medicine interventions. The people delivering these therapies see results every day. Almost none of them capture those results in a way the wider field can use.
Beacon Clinical Registry lowers the barrier. We take the regulatory machinery — protocol drafting, IRB submission, ClinicalTrials.gov registration, PRO instrument licensing, data management, and publication support — and price it at a level that a single-clinician or small-practice innovator can actually afford. $2K–$7K to register; $100–$300 a month to run.
The more awareness that peer-reviewed data brings to these innovative treatments, the better for humanity. That is the principle. Everything else is mechanics.
Our affiliation with Healing Hope International
Beacon Clinical Registry operates in affiliation with Healing Hope International, a 501(c)(3) nonprofit research and education organization. HHI provides the PI of record on registered studies, the ethics-oversight backbone, and the international research-network credibility.
Beacon, as the commercial service arm, handles the practitioner-facing work: intake, protocol drafting, registration, site support, and publication. This structure lets us serve clinicians as a for-profit service while keeping the scientific oversight anchored in a mission-driven research organization.
Leadership
Tamara C Tamas
Founder & Principal Investigator
Biochemist and regulatory strategist with 15+ years of research experience bridging cutting-edge cellular therapies and patient care. Principal Investigator on multiple ClinicalTrials.gov-registered observational studies. Has facilitated treatment access for 200+ patients across 14 countries and now makes that same regulatory machinery available to independent clinicians.
Credentials
- • MS, Biopharmaceutical Regulatory Affairs
- • BS, Chemistry (Biochemistry Focus)
- • cGMP Cell Therapy Manufacturing & Cleanroom Operations
- • Principal Investigator — ClinicalTrials.gov (multiple active studies)
- • 200+ patients across 14 countries